Series: A
Co-Investors: Asabys partners
Earlier Investors: Asabys partners
Date of Investment: September 2023
Investment Amount: $2,000,000 – Convertible note ($150M pre-money valuation)
Summary: XRHealth is a virtual health clinic using extended reality technology for cognitive testing, pain management, and psychological assessments, providing telehealth services to patients at home.
Product offering: XRHealth is one of the first companies registered with the FDA as a medical device. The company offers a virtual reality app compatible with VR headsets. Solutions are offered in three key categories:
-
- VRCogni Series: Retrain a user’s brain with game-like medical applications designed to support user’s memory, attention, and reaction time.
- VRPhysio Series: Assess a user’s range of motion, mobility, and more with advanced technology. It can also train a user’s body with fun, immersive games.
- VRReliever Series: Replaces a user’s unhealthy thoughts and behaviors with healthier ones with cognitive-behavioral therapy (CBT) inspired therapeutic apps.
- Completed merger with Amelia Virtual Care, turning XRHealth into the world’s largest XR therapeutics platform.
- Currently operating in US, Israel, and Australia covering of 70M lives. Company projects they will reach 200M lives covered by the end of 2024.
- Over 500k VR session completed to date through 2023.
- Secured contacts with Medicare in 16 states. Company intends to further expand into clinics and rehab centers in 2024.
XRHealth is a virtual health clinic using extended reality technology for cognitive testing, pain management, and psychological assessments, providing telehealth services to patients at home.
